Newspaper logo  
 
 
Local Gov’t Stories, Events

Ref. : Civic Events

Ref. : Arts & Education Events

Ref. : Public Service Notices

Travel
Books, Films, Arts & Education

04.23 US business schools failing on climate change

Letters

Ref. : Letters to the editor

Health Care & Environment

04.24 Disney, the Gap and Pepsi urged to quit US Chamber of Commerce ["Its a small world after all..." – Disney]

04.24 Why we joined the March for Science

04.23 The trees that make Southern California shady and green are dying. Fast. [video]

04.23 March for Science puts Earth Day focus on global opposition to Trump [videos]

04.22 Neil deGrasse Tyson on the Threat of Science Denial [4 videos]

04.22 These Images Carry a Dire Warning About Climate Change

04.22 Nearly 40 million people live in UK areas with illegal air pollution [rather than maximizing profit from fossil fuels, better policy embracing science could dramatically improve life on earth]

04.22 Bill Nye the Science Guy on Trump: 'We are in a dangerous place' [we need the opposite of Trump to advance the country and world]

04.22 Electric flying car that takes off vertically could be future of transport [videos; new solid-state lithium battery technolgy—led? by Dr. Goodenough—may double performance and recharge speed while eliminating risk of lithium battery fire]

04.22 Global 'March for Science' protests call for action on climate change

04.21 Sale Of Seawater Desalination Technology In China

04.21 Britain set for first coal-free day since the industrial revolution [Hurrah!]

04.20 How to Stop Drug Price Gouging [and why hasn't the U.S. Government done this?]

04.20 East Chicago Needs More than "Basics" from Scott Pruitt's EPA

04.20 The Monsanto Tribunal’s Legal Opinion Reinforces Movements’ Struggle for Basic Human Rights

04.20 Pollution is killing our children. Here’s how we can save them

News Media Matters

Daily: FAIR Blog
The Daily Howler

US Politics, Policy & 'Culture'

04.24 Nearing 100 Days In, Trump is Least Popular President in Modern History

04.24 Comey Tried to Shield the F.B.I. From Politics. Then He Shaped an Election.

04.23 Trump’s Organized Crime Ties Bring Blackmail to the White House

04.23 Trump: 100 days that shook the world – and the activists fighting back

04.22 The GOP’s Latest Health-care Plan Is Comically Bad

04.22 Group of Mental Health Professionals Warn Trump's State 'Putting Country in Danger' [the Goldwater Rule is excessive courtesy if it shields Trump from suspect mental health evaluation]

04.22 Texas Keeps Failing to Convince Federal Courts Its Voting Laws Aren't Racist [it’s like immorality is their code of conduct]

Justice Matters
High Crimes?
Economics, Crony Capitalism

04.23 Elizabeth Warren on Big Banks and Their (Cozy Bedmate) Regulators

04.23 The evidence is piling up — Silicon Valley is being destroyed

04.22 THE REAL TRUMP AGENDA: HELPING BIG BUSINESS

04.22 In Latest Populist Betrayal, Trump Executive Order Unchains Wall Street Greed [misfeasance, nonfeasance, and malfeasance]

International

04.24 Life in Africa’s Last Colony

04.24 Trump push for border wall threatens to cause government shutdown [since inexpensive electric flying cars are about to be sold, building any wall is just stupid]

04.24 Chinese leader urges restraint over North Korea in call with Trump

04.24 Trump Thinks This Is Pro-Life?

04.24 How France Voted

04.24 Asking for Trouble on Iran

04.23 The Observer view on the French presidential election

04.23 French election 2017: voters go to the polls in wide-open contest [videos]

04.21 A tale of two droughts: one killed 260,000 people, the other none. Why?

04.21 'We've never seen this drought, this disease': Somali families bury their dead

04.21 A Complete Breakdown: Extremists on Left and Right Push France to the Brink

04.21 UN security council warns North Korea to stop nuclear tests or face sanctions

04.21 Housing crisis: more than 200,000 homes in England lie empty

We are a non-profit Internet-only newspaper publication founded in 1973. Your donation is essential to our survival.

You can also mail a check to:
Baltimore News Network, Inc.
P.O. Box 42581
Baltimore, MD 21284-2581
Google
This site Web
  Big Pharma Wins Big in Health Care Reform

COMMENTARY:

Big Pharma Wins Big in Health Care Reform

by James Ridgeway
First published in his blog Unsilent Generation yesterday, 22 March 2010
To a large extent, the “debate” over health care was a show debate, an extended round of Washington smoke and mirrors. The administration early on cut its deal with Big Pharma, and pretty much stuck to it throughout the process.

The Republicans look a sour lot this morning, but the pharmaceutical industry, which helps foot the campaign bills of a sizeable chunk of members of both parties, is delighted with the legislation, and with its Democratic friends in the White House and on the Hill.

Members of Congress in both parties generally have lined up behind the insurance and pharmaceutical industries from the get go. So it should come as no surprise that the Democrats, who long ago gave up any pretence of opposing corporate power, found a way to accomodate the pharmaceutical companies on the way to its tepid reform. To a large extent, the “debate” over health care was a show debate, an extended round of Washington smoke and mirrors. The administration early on cut its deal with Big Pharma, and pretty much stuck to it throughout the process.

In fact, the Dems actually made the drugsters look good, celebrating the industry’s generous “concessions” and “discounts” while ensuring that no real threat to Big Pharma’s profits would make their way into the final bill.

The industry’s main goal from the very beginning has been to fend off any government power to negotiate or seriously regulate drug prices–and this they did.

Big Pharma’s second big win was to prevent any measure that would have opened the way for American consumers to buy less expensive drugs abroad, especially from Canada.

At the same time, the supposed give-backs by the drug industry are projected to more than pay for themselves. The much-lauded discounts on brand name drugs for seniors in the Medicare prescription drug program, for example, are good for Big Pharma because they discourage oldsters from switching to generics.

And more insured people simply mean more money coming into the coffers, for Big Pharma as well as for the insurance industry.

Confirmation of the industry analysis came early in the day from the stock market, where drug stocks initially remained level; there certainly was no rush to dump shares, which is what would be expected if the bill actually represented any threat to profits. And by 1 p, EST, CNN Money was reporting a rally in health care stocks.

“I was unable to find anything in there that would cause me to have anxiety if I were a shareholder in a pharmaceutical company,” Ira Loss, a senior health-care analyst at the research firm Washington Analysis, told Dow Jones. According to the ticker story:

Billy Tauzin, who led the industry’s negotiations on health care with lawmakers, said overall drug makers fare well. “While we’re not totally happy,” Tauzin began, “we generally feel like it tracks with our principles.”

Sanofi-Aventis SA (SNY) Chief Executive Christopher Viehbacher said in an interview that the impact of the legislation will be neutral to slightly negative “but better for the industry than if healthcare reform didn’t pass.”

Tauzin, head of the Pharmaceutical Research and Manufacturers of America or PhRMA, and Viehbacher said getting protection for brand-name biologics is among the important provisions for the industry. Drug makers pushed hard to get 12 years of exclusive market protection while the White House and some lawmakers wanted to lower the protection to seven years.

Despite fees and rebates imposed by the legislation, “analysts say drug makers will end up recouping those costs through new customers: The bill would provide insurance coverage to an additional 32 million Americans.” The Dow Jones story continues:

Chalk up another good round for Pharma and Biotech in health care reform,” began a note to clients Friday from Concept Capital, a research firm.Ken Tsuboi, co-manager of the Allianz RCM Wellness Fund, sees the impact of bill, and its $90 billion in concessions over 10 years, as relatively minor in an industry that has annual global sales of about $750 billion, with about $300 billion in the U.S., and margins close to 30%.”I think that it is actually a pretty good deal for Pharma,” Tsuboi said.

The GOP, which purports to be the party of big business, ought to be applauding at least these portions of the health care reform—and perhaps when the cameras go away, some of them will quit bitching and count their blessings. As for the obnoxious Tea Party gang, if they start threatening the real power in this country, which is vested in corporations, they may well find themselves whipped and isolated.


Born in 1936, James Ridgeway has been reporting on politics for more than 45 years. He is currently Senior Washington Correspondent for Mother Jones, and recently wrote a blog on the 2008 presidential election for the Guardian online. He previously served as Washington Correspondent for the Village Voice; wrote for Ramparts and The New Republic; and founded and edited two independent newsletters, Hard Times and The Elements.

Ridgeway is the author of 16 books, including The Five Unanswered Questions About 9/11, It’s All for Sale: The Control of Global Resources, and Blood in the Face: The Ku Klux Klan, Aryan Nations, Nazi Skinheads, and the Rise of a New White Culture. He co-directed a companion film to Blood in the Face and a second documentary film, Feed, and has co-produced web videos for GuardianFilms.

Additional information and samples of James Ridgeway’s work can be found at JamesRidgeway.net and at his newest web site, Solitary Watch.

This article is republished in the Baltimore Chronicle with permission of the author.



Copyright © 2010 The Baltimore News Network. All rights reserved.

Republication or redistribution of Baltimore Chronicle content is expressly prohibited without their prior written consent.

Baltimore News Network, Inc., sponsor of this web site, is a nonprofit organization and does not make political endorsements. The opinions expressed in stories posted on this web site are the authors' own.

This story was published on March 23, 2010.
 



Public Service Ads:
Verifiable Voting in Maryland